23 October 2015 - Iroko Pharmaceuticals announced today that the United States FDA approved Vivlodex (meloxicam) capsules for the management of patients with osteoarthritis pain.

For more details, go to: https://www.iroko.com/press-releases/iroko-pharmaceuticals-receives-fda-approval-for-vivlodex-first-low-dose-solumatrix-meloxicam-for-osteoarthritis-pain/